Novartis' most-sold drugs are accessible with insurance coverage, yet expensive in general (2023)
Around 2 billion (Bn) people worldwide lack access to essential medications1;p1. At least 10% of the household budget of over 800 million (Mn) people goes into healthcare expenditure, and 100 Mn people are pushed to extreme poverty due to unafford...
Register to read the full analysis —or— Upgrade to access more features
#cost
#price
#pricing
#returns
Actual Direct Impact
Assess the impact materiality of this Topic for Novartis
How negative/positive is the impact of Novartis for this Topic?
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.